From Analysis:
This analysis aims to elucidate the mechanisms by which gut microbiome dysbiosis influences Parkinson's disease pathogenesis through the gut-brain axis, situated within the neurodegeneration domain.
Molecular Mechanism and Rationale
The gut-brain axis represents a critical bidirectional communication network that fundamentally influences neurodegeneration through microbiome-derived metabolites, particularly short-chain fatty acids (SCFAs). In Parkinson's disease (PD), the progressive depletion of butyrate-producing bacterial taxa—specifically Clostridium clusters IV and XIVa, Roseburia intestinalis, and Faecalibacterium prausnitzii—initiates a cascade of molecular events that compromise both peripheral and central nervous system homeostasis.
...No AI visual card yet
Curated pathway diagram from expert analysis
flowchart TD
A["HDAC3 Class I
Histone Deacetylase 3"]
B["NCoR/SMRT Complex
Transcriptional Co-repressor"]
C["H3K9 Deacetylation
Chromatin Condensation"]
D["Inflammatory Gene Repression
NFKB Pathway Suppression"]
E["Microglial Activation
Pro-inflammatory Response"]
F["TREM2 Downregulation
DAM Transition Impaired"]
G["Phagocytic Capacity
Amyloid Clearance Reduced"]
H["Synaptic Dysfunction
Memory-Related Gene Expression"]
I["Cognitive Decline
Neurodegeneration Progression"]
A --> B
B --> C
C --> D
D --> E
E --> F
F --> G
G --> H
H --> I
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style I fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
Median TPM across 13 brain regions for HDAC3, GPR41 (FFAR3), GPR43 (FFAR2), Nrf2, HMOX1 from GTEx v10.
Title: Loss of butyrate-producing gut bacteria (Clostridium spp., Roseburia, Faecalibacterium) depletes systemic and CNS butyrate, driving neuroinflammation and impairing intestinal barrier integrity in PD.
Mechanism: Commensal anaerobes depleted in PD fecal samples (CrossRef 1; 10.1136/gutjnl-2021-326974) produce short-chain fatty acids (SCFAs), predominantly butyrate. Butyrate acts as a histone d
The five hypotheses form an interconnected mechanistic framework linking gut microbiome dysbiosis to α-synuclein pathology via distinct pathways. Below I evaluate each hypothesis against standard falsification criteria: specificity of mechanism, confounded causal inference, translational gaps, and empirical disconfirmation.
| Issue | Description |
|-------|-------------|
| Mechanism specificity | The hypothesis conflates correlat
Each hypothesis is evaluated on five dimensions: (D)ruggability (target tractability and therapeutic modality), (B)iomarkers/Model Systems (validation readiness), (C)linical-Development Constraints (trial design and patient-selection challenges), (S)afety (known and theoretical liabilities), and (T)imeline/Cost (realistic development trajectory). An integrated Feasibility Score (0–1) weights these dimensions toward clinical translatability. The skeptical re-anal
{
"ranked_hypotheses": [
{
"title": "SCFA-Producing Bacterial Depletion → Loss of Neuroprotective Microenvironment",
"description": "Depletion of butyrate-producing commensals (Clostridium spp., Roseburia, Faecalibacterium) in PD fecal samples reduces systemic and CNS butyrate, impairing HDAC-mediated microglial anti-inflammatory responses, intestinal barrier integrity, and dopaminergic neuron mitophagy. The mechanism proposes a dual-hit model: SCFA deficiency causes gut epithelial tight junction breakdown (systemic inflammation) while simultaneously reducing microglial clear
No clinical trials data available
Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.
No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.
Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.
High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.
Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.
Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.
Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.
No DepMap CRISPR Chronos data found for HDAC3, GPR41 (FFAR3), GPR43 (FFAR2), Nrf2, HMOX1.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No governance decisions recorded for this hypothesis.
Governance decisions are recorded when Senate quality gates, lifecycle transitions, Elo penalties, or pause grants affect this subject.
Molecular pathway showing key causal relationships underlying this hypothesis
graph TD
H1["H1"] -->|associated with| HDAC3["HDAC3"]
H1_1["H1"] -->|associated with| GPR41["GPR41"]
H1_2["H1"] -->|associated with| GPR43["GPR43"]
H1_3["H1"] -->|associated with| NFE2L2__Nrf2_["NFE2L2 (Nrf2)"]
H1_4["H1"] -->|associated with| HMOX1["HMOX1"]
H2["H2"] -->|associated with| CLDN1["CLDN1"]
H2_5["H2"] -->|associated with| OCLN["OCLN"]
H2_6["H2"] -->|associated with| TJP1__ZO_1_["TJP1 (ZO-1)"]
H2_7["H2"] -->|associated with| LBP["LBP"]
H2_8["H2"] -->|associated with| CD14["CD14"]
H2_9["H2"] -->|associated with| TLR4["TLR4"]
H2_10["H2"] -->|associated with| MYD88["MYD88"]
style H1 fill:#4fc3f7,stroke:#333,color:#000
style HDAC3 fill:#ce93d8,stroke:#333,color:#000
style H1_1 fill:#4fc3f7,stroke:#333,color:#000
style GPR41 fill:#ce93d8,stroke:#333,color:#000
style H1_2 fill:#4fc3f7,stroke:#333,color:#000
style GPR43 fill:#ce93d8,stroke:#333,color:#000
style H1_3 fill:#4fc3f7,stroke:#333,color:#000
style NFE2L2__Nrf2_ fill:#ce93d8,stroke:#333,color:#000
style H1_4 fill:#4fc3f7,stroke:#333,color:#000
style HMOX1 fill:#ce93d8,stroke:#333,color:#000
style H2 fill:#4fc3f7,stroke:#333,color:#000
style CLDN1 fill:#ce93d8,stroke:#333,color:#000
style H2_5 fill:#4fc3f7,stroke:#333,color:#000
style OCLN fill:#ce93d8,stroke:#333,color:#000
style H2_6 fill:#4fc3f7,stroke:#333,color:#000
style TJP1__ZO_1_ fill:#ce93d8,stroke:#333,color:#000
style H2_7 fill:#4fc3f7,stroke:#333,color:#000
style LBP fill:#ce93d8,stroke:#333,color:#000
style H2_8 fill:#4fc3f7,stroke:#333,color:#000
style CD14 fill:#ce93d8,stroke:#333,color:#000
style H2_9 fill:#4fc3f7,stroke:#333,color:#000
style TLR4 fill:#ce93d8,stroke:#333,color:#000
style H2_10 fill:#4fc3f7,stroke:#333,color:#000
style MYD88 fill:#ce93d8,stroke:#333,color:#000
neurodegeneration | 2026-04-01 | completed
No comments yet. Be the first to comment!